Gilead testing inhaled remdesivir, coronavirus trials start in August - Business Insider

. While it's not an approval, the authorization allows for more hospitalized patients to receive the drug.Associated Press

And Gilead will also start studying combination therapies where remdesivir is given along with other experimental treatments. This could be particularly helpful given a growing understanding of COVID-19. While the main issue in the earlier stages of the disease is fighting the virus, later on critically ill patients often suffer from a runaway immune response. Their own bodies kick into overdrive and can severely damage their own lungs.

Further trials will narrow in on specific patient groups where COVID-19 may be significantly different. These include testing remdesivir in children, pregnant women, and patients with end-stage renal disease, O'Day wrote.

Gilead is our dystopian future depicted in The Handmaid's Tale.

Colombia Últimas Noticias, Colombia Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Trump ignored coronavirus task force concerns about Tulsa rally - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web. Did they also warn the BlackLivesMatter protesters the dangers of rioting and looting without wearing masks or observing social distancing? Double standards. Protests were okay then
Fuente: BusinessInsider - 🏆 729. / 51 Leer más »

China: European strain of the coronavirus blamed for Beijing outbreak - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web. Yea just following what China says, like always. Wait..... Is that OK to talk about the origin of the viruses now? Sure..... WHO said so, it must be the opposite
Fuente: BusinessInsider - 🏆 729. / 51 Leer más »